Ignite Creation Date:
2025-12-25 @ 4:30 AM
Ignite Modification Date:
2026-02-20 @ 6:03 PM
Study NCT ID:
NCT00055718
Status:
COMPLETED
Last Update Posted:
2013-12-18
First Post:
2003-03-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy
Sponsor:
Herbert Irving Comprehensive Cancer Center
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
CDR0000270914
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |